This paper examines courses of action that could help the bank could adapt to shifting development priorities. It investigates how country eligibility standards might evolve and how the bank might start to break away from its traditional “loans to countries” model.
The discovery of antibiotics in the early 20th Century was a major breakthrough for human health, markedly reducing the infection threat from minor cuts, surgery, and cancer treatment.
Guatemala is one of the most unequal countries in Latin America and has the highest incidence of poverty. The indigenous population is more than twice as likely to be poor than the nonindigenous group.
On March 19, 2015, senior fellow and director of CGD’s Rethinking US Development Policy Initiative Ben Leo testified before the Senate Foreign Relations Committee Subcommittee on Africa and Global Health Policy at a hearing about the potential for greater US trade and investment with S
In 2013, our CGD colleagues Julia Clark and David Roodman designed a low-cost quantitative approach to ranking think tank performance. We applied their methodology in early 2015 to produce an updated ranking of US and international development think tanks on the basis of 2014 data. The rankings aim to provide a transparent and objective method of assessing the influence of select think tanks.
Bringing US Development Finance into the 21st Century: Proposal for a Self-Sustaining, Full-Service USDFC
The imperative for US development finance has increased significantly due to a number of factors over the last decade. There is growing demand for private investment and finance from businesses, citizens, and governments in developing countries. Given the scale of challenges and opportunities, especially in promoting infrastructure investments and expanding productive sectors, there is an increasingly recognized need to promote private sector-based solutions.
Large wage differences between countries (“place premiums”) are well documented. Theory suggests that factor price convergence should follow increased migration, capital flows, and commercial integration.
Donors play a significant role in funding medicines and other commodities in global health. Of the approximately US $28.2 billion spent by donors in 2010, approximately 40% went towards medicines, vaccines and other health commodities, mainly in sub-Saharan Africa. The efficiency of this spend is therefore of great concern, given the large variability in supply chain costs.
On a chilly Monday morning on February 16th, 2009, I walked into the New Government Complex in Harare’s Central Avenue. As I strode for the very first time down a poorly lit corridor, eyes strained and necks stretched behind wide open doors to catch a glimpse of the newcomer with a reputation for short temper. I was ushered into a comfortable office that was to become my home for the next four and a half years.